Physician
Hematology & Oncology
Based on specialty. Actual services may vary — contact the provider's office to confirm.
Based on CMS Medicare Provider Utilization data for 2023. These represent what this physician charged Medicare, not necessarily what you would pay. Compare with other physicians
| Procedure | Avg Charge | Medicare Allowed | Medicare Paid | Services |
|---|---|---|---|---|
78815 Nuclear medicine study from skull base to mid-thigh with ct scan | $4,260 | $890 | $705 | 194 |
71260 Ct scan of chest with contrast | $2,051 | $61 | $43 | 119 |
71250 Ct scan of chest without contrast | $1,498 | $65 | $49 | 36 |
A9595 Piflufolastat f-18, diagnostic, 1 millicurie | $1,226 | $589 | $470 | 479 |
74177 Ct scan of abdomen and pelvis with contrast | $1,188 | $214 | $162 | 112 |
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | $1,096 | $106 | $85 | 1,104 |
J9217 Leuprolide acetate (for depot suspension), 7.5 mg | $1,077 | $171 | $136 | 213 |
74176 Ct scan of abdomen and pelvis without contrast | $899 | $94 | $71 | 20 |
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | $831 | $251 | $201 | 144 |
96416 Administration of prolonged chemotherapy into vein | $550 | $117 | $92 | 73 |
70491 Ct scan of soft tissue of neck with contrast | $470 | $85 | $59 | 11 |
99205 New patient office or other outpatient visit, 60-74 minutes | $460 | $201 | $161 | 11 |
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $455 | $168 | $130 | 29 |
96413 Administration of chemotherapy into vein, 1 hour or less | $366 | $119 | $95 | 608 |
99204 New patient office or other outpatient visit, 45-59 minutes | $364 | $159 | $121 | 75 |
99215 Established patient office or other outpatient visit, 40-54 minutes | $324 | $170 | $136 | 48 |
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | $309 | $126 | $101 | 55 |
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | $281 | $4 | $3 | 600 |
96409 Administration of chemotherapy into vein using push technique | $276 | $89 | $72 | 20 |
J9206 Injection, irinotecan, 20 mg | $270 | $2 | $2 | 409 |
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $243 | $115 | $92 | 43 |
99214 Established patient office or other outpatient visit, 30-39 minutes | $240 | $121 | $91 | 524 |
99203 New patient office or other outpatient visit, 30-44 minutes | $237 | $104 | $74 | 25 |
96417 Administration of additional new drug or substance into vein, 1 hour or less | $220 | $58 | $46 | 164 |
J9312 Injection, rituximab, 10 mg | $214 | $80 | $64 | 2,220 |
J2997 Injection, alteplase recombinant, 1 mg | $201 | $82 | $66 | 30 |
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | $196 | $58 | $47 | 116 |
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | $192 | $67 | $54 | 130 |
96411 Administration of additional new drug or substance into vein using push technique | $192 | $48 | $38 | 62 |
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | $192 | $27 | $22 | 1,922 |
96360 Infusion into a vein for hydration, 31-60 minutes | $182 | $29 | $23 | 65 |
J9070 Cyclophosphamide, 100 mg | $171 | $18 | $15 | 219 |
J9022 Injection, atezolizumab, 10 mg | $169 | $80 | $64 | 3,432 |
J9035 Injection, bevacizumab, 10 mg | $168 | $71 | $56 | 2,117 |
99213 Established patient office or other outpatient visit, 20-29 minutes | $165 | $85 | $62 | 365 |
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $154 | $76 | $60 | 170 |
J9173 Injection, durvalumab, 10 mg | $145 | $78 | $62 | 4,170 |
96374 Injection of drug or substance into vein | $141 | $32 | $25 | 11 |
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | $138 | $26 | $21 | 205 |
82024 Adrenocorticotropic hormone (acth) level | $136 | $38 | $38 | 124 |
82378 Carcinoembryonic antigen (cea) protein level | $118 | $19 | $19 | 64 |
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | $116 | $31 | $25 | 59 |
96415 Administration of chemotherapy into vein, each additional hour | $114 | $26 | $21 | 117 |
J2469 Injection, palonosetron hcl, 25 mcg | $113 | $1 | $1 | 1,990 |
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | $110 | $19 | $15 | 65 |
J9271 Injection, pembrolizumab, 1 mg | $110 | $51 | $40 | 18,800 |
J9041 Injection, bortezomib, 0.1 mg | $105 | $7 | $5 | 2,194 |
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | $103 | $48 | $38 | 30 |
J9045 Injection, carboplatin, 50 mg | $97 | $2 | $2 | 412 |
96523 Irrigation of implanted venous access drug delivery device | $82 | $24 | $19 | 24 |
Showing top 50 of 95 procedures by charge amount.
Search published hospital rates side by side to find lower cash prices and stronger negotiating leverage.
Physician identity data from the NPPES NPI Registry. Last synced 3/28/2026.